Radiofrequency Ablation Devices Market to See High Demand Across Oncology Segments

The global radiofrequency ablation (RFA) devices market is expected to reach USD 12.5 billion by 2032, rising from USD 4.3 billion in 2022. This growth reflects a strong compound annual growth rate (CAGR) of 11.6% from 2023 to 2032. One of the major factors driving this market is the increasing burden of chronic diseases. According to the World Health Organization (WHO), cancer caused nearly 10 million deaths in 2020, making it one of the leading global health concerns. RFA is used to treat tumors in organs like the liver, lungs, and kidneys, offering a minimally invasive option with fewer complications.